Prostate Cancer ADT Increases Bone Fracture Risk
Investigators examined the risk of bone fracture associated with different forms of androgen deprivation therapy.
Investigators examined the risk of bone fracture associated with different forms of androgen deprivation therapy.
Authors strongly recommend treatment with denosumab or an intravenous bisphosphonate for adults with HCM
Results showed that treatment with abaloparatide for 12 months resulted in significant increases in bone mineral density compared with placebo.
According to a long-term safety study and a separate FDA internal study, Prolia had an increased risk of hypocalcemia in patients with advanced kidney disease on dialysis.
Among adults not selected for vitamin D deficiency, low bone mass, or osteoporosis, no effect seen on total, nonvertebral, or hip fracture risk
Risk for major osteoporotic fractures up for insulin versus metformin for those with HbA1c <7 percent, BMI <25 kg/m2
Increased risk seen using frequentist approach and Bayesian approach; significant association also seen in subgroup analyses
BCX9250 is an investigational activin receptor-like kinase-2 (ALK-2) inhibitor designed to stimulate normal bone growth and renewal.
Cerament G is a resorbable, gentamicin-eluting ceramic bone void filler.